Epoetin theta

Epoetin theta
Clinical data
Trade namesBiopoin, Eporatio
License data
ATC code
  • None
Legal status
Legal status

Epoetin theta, sold under the brand name Biopoin among others, is a copy of the human hormone erythropoietin.[1][2]

The most common side effects include shunt thrombosis (clots that can form in blood vessels of patients on dialysis, a blood clearance technique), headache, hypertension (high blood pressure), hypertensive crisis (sudden, dangerously high blood pressure), skin reactions, arthralgia (joint pain) and influenza (flu)-like illness.[1]Epoetin theta was approved for medical use in the European Union in October 2009.[1] It is on the World Health Organization's List of Essential Medicines.[3]

Medical uses

Epoetin theta is indicated for the treatment of symptomatic anemia in adults.[1]

References

  1. 1 2 3 4 5 "Biopoin EPAR". European Medicines Agency (EMA). Retrieved 26 January 2021. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  2. 1 2 "Eporatio EPAR". European Medicines Agency (EMA). Retrieved 26 January 2021. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  3. ↑ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

attribution contains material copied from Biopoin | European Medicines Agency https://www.ema.europa.eu/en/medicines/human/EPAR/biopoin 2021

  • "Epoetin theta". Drug Information Portal. U.S. National Library of Medicine.


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.